IP Library Granted Patent US 7,041,169
Granted Patent B2
US 7,041,169 · App. 10/688,123 · Granted May 9, 2006

Methods of generating and screening for high free energy forms in capillaries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,041,169
App. No.
10/688,123
Granted
May 9, 2006
Kind
B2
Abstract

A method for generating and isolating a high free energy form of a compound or a mixture of compounds comprises the steps of placing a sample in a capillary tube, solidifying the sample in the capillary tube, and isolating a high free energy form of the sample. A method for searching for a high free energy form of a sample comprises the steps of placing the compound or mixture in a capillary tube, generating a solid in the capillary tube, and determining whether a high free energy form of the sample was generated. The sample may be a compound or mixture.

Claims (46)

1. A method of generating and screening for one or more high free energy forms of a compound, element or mixture, said method comprising the steps of:

disposing a non-solid sample of the compound, element or mixture in a plurality of capillary tubes;

solidifying the sample in the plurality of capillary tubes, whereby a plurality of solids is generated; and

determining whether one or more high free energy forms were generated using an analytical method selected from the group consisting of visual analysis, microscopic analysis, thermal analysis, diffraction analysis, and spectroscopic analysis.

2. The method of claim 1 wherein the solidifying step comprises crystallizing the sample.

3. The method of claim 1 wherein the solidifying step comprises the use of an antisolvent.

4. The method of claim 1 wherein the solidifying step is selected from the group consisting of solvent evaporation, antisolvent addition, gel diffusion, and thin-layer deposition.

5. The method of claim 1 , further comprising the step of preparing the sample from a supersaturated solution of the compound, element or mixture.

6. The method of claim 1 , wherein said isolated high free energy form is stabilized within the capillary tube by adding a stabilizing agent.

7. The method of claim 6 , wherein said isolated high free energy form is stable within the capillary tube for at least 24 hours.

8. The method of claim 1 , further comprising the step of stabilizing the high free energy form for at least 24 hours essentially by maintaining the high free energy form in the capillary tube.

9. The method of claim 1 , wherein the sample is placed in at least two sets of capillary tubes, and at least one set differs from at least one other set.

10. The method of claim 9 , wherein the capillary tubes of said at least one set have a different inner diameter than the capillary tubes of said at least one other set.

11. The method of claim 9 , wherein the sample is placed in at least four sets of capillary tubes, and each set differs from the other set with respect to the size or surface of the capillary tubes within said sets.

12. The method of claim 1 , wherein said at least one capillary tube is coated with a substance on the interior of said tube.

13. The method of claim 1 , wherein the step of determining whether the high free energy form was generated comprises generating data indicative of the relative free energy of the generated form and comparing said data to data relating to a known form.

14. The method of claim 1 wherein the high energy forms exhibit different colors.

15. The method of claim 1 , further comprising identifying the high free energy forms by visual analysis.

16. The method of claim 1 wherein the microscopic analysis is electron microscopy.

17. The method of claim 1 wherein the diffraction analysis is x-ray diffraction.

18. The method of claim 1 wherein the spectroscopic analysis is infrared spectroscopy.

19. The method of claim 1 further comprising analyzing the known solid form to determine the free energy.

20. The method of claim 1 , wherein the step of determining whether one or more high free energy forms were generated comprises determining whether a distribution of solid forms occurred.

21. The method of claim 1 , wherein the step of determining whether a high free energy form was generated comprises thermal analysis.

22. The method of claim 21 wherein the thermal analysis is determining the melting points.

23. A method of generating and screening for one or more high free energy forms of a compound, element or mixture, said method comprising the steps of:

disposing a non-solid sample of the compound, element or mixture in a plurality of capillary tubes;

solidifying the sample in the plurality of capillary tubes, whereby a plurality of generated solids is generated;

determining whether one or more high free energy forms were generated using an analytical method selected from the group consisting of visual analysis, microscopic analysis, thermal analysis, diffraction analysis, and spectroscopic analysis;

determining the number of occurrences of each of said solid forms; and

assigning a relative free energy to each of said solid forms based on the number of occurrences, wherein a high free energy form is associated with a lower number of occurrences.

24. The method of claim 23 wherein the plurality comprises at least 10 capillary tubes.

25. The method of claim 24 wherein the plurality comprises at least 50 or more capillary tubes.

26. The method of claim 25 wherein the plurality comprises at least about 150 capillary tubes.

27. The method of claim 23 , wherein the plurality of capillary tubes comprises at least two sets of capillary tubes, and at least one set differs from at least one other set.

28. The method of claim 27 , wherein the capillary tubes of said at least one set have a different inner diameter than the capillary tubes of said at least one other set.

29. The method of claim 27 , wherein the plurality of capillary tubes comprises at least two four of capillary tubes, and each set differs from the other sets with respect to the size or surface of the capillary tubes within said sets.

30. The method of claim 23 , wherein said at least one capillary tube is coated with a substance on the interior of said tube.

31. A method of generating and screening for one or more high free energy forms of a compound, element or mixture, said method comprising the steps of:

disposing a non-solid sample of the compound, element or mixture in a plurality of capillary tubes;

solidifying the sample in the plurality of capillary tubes, whereby a plurality of solids is generated; and

determining whether one or more high free energy forms were generated.

32. The method of claim 31 , wherein the step of determining whether a high free energy form was generated comprises visual analysis.

33. The method of claim 31 , wherein the step of determining whether a high free energy form was generated comprises microscopic analysis.

34. The method of claim 31 , wherein the step of determining whether a high free energy form was generated comprises diffraction analysis.

35. The method of claim 31 , wherein the step of determining whether a high free energy form was generated comprises spectroscopic analysis.

Assignments (15)
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON SEPTEMBER 1, 2017, AT REEL/FRAME 043746/0621 Recorded Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
Reel/Frame 054252/0687 →
FIRST LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC-BY ITS SOLE MEMBER: ALO ACQUISITION LLC
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING LLC-BY ITS SOLE MEMBER:ALO ACQUISITION LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded May 26, 2015
From: AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 035710/0880 →
ASSIGNMENT EFFECTIVE 13 FEB 2015 Recorded Apr 23, 2015
From: APTUIT (WEST LAFAYETTE), LLC
To: AMRI AMERICIUM, LLC
Reel/Frame 035492/0830 →
CHANGE OF NAME Recorded Apr 23, 2015
From: AMRI AMERICIUM, LLC
To: AMRI SSCI, LLC
Reel/Frame 035487/0184 →
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: APTUIT (WEST LAFAYETTE), LLC; APTUIT (KANSAS CITY), LLC
Reel/Frame 027793/0505 →
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2012
From: JPMORGAN CHASE BANK, N.A.
To: APTUIT (KANSAS CITY), LLC; APTUIT (WEST LAFAYETTE), LLC
Reel/Frame 027793/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2011
From: APTUIT (KANSAS CITY), LLC
To: APTUIT (WEST LAFAYETTE), LLC
Reel/Frame 027253/0965 →
AMENDED & RESTATED PATENT SECURITY AGREEMENT Recorded Aug 18, 2009
From: S.S.C.I., INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 023107/0244 →
MERGER Recorded Dec 20, 2008
From: SSCI, INC.
To: APTUIT (KANSAS CITY), LLC
Reel/Frame 022012/0049 →
SECURITY AGREEMENT Recorded Aug 24, 2007
From: SSCI, INC.
To: JPMORGAN CHASE BANK, N.A. AS COLLATERAL AGENT
Reel/Frame 019744/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2006
From: MORRIS, KENNETH R.; STAHLY, G. PATRICK
To: PRUDUE RESEARCH FOUNDATION; S.S.C.I., INC.
Reel/Frame 018350/0016 →